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ABSTRACT
Microcapsules play an important role in chemical, biomedical, and medical 
research. O f importance is their potential use as bio-sensors, as microreactors, and for 
drug delivery. In this dissertation, Computational Fluid Dynamics methodology is used to 
model the generation of droplets or cores (using alginate and oil) and to determine from 
the model process parameters needed for generating cores of homogeneous size for the 
manufacturing of microcapsules. Also, material diffusion through a microcapsule for 
controlled release is modeled based on finite difference methodology. The model was 
applied to experimental data on dextran release from microcapsules in order to estimate 
the diffusion coefficients in the core and wall of a microcapsule.
Results o f the study showed that the velocities o f alginate and oil and their ratio 
were considered as two important factors for determining droplet size. One can obtain the 
desired droplet size by adjusting these two factors. Also, it was observed that the 
properties o f the two immiscible phases can influence the variance. A low viscosity of 
one of the phases (the non-oil phase) produced a small variance for droplet size. The flow 
channel was straight with a width o f 100 micrometers. In future work, it would be of 
interest to determine if channel width and or geometry will have any effect on droplet 
size and variance.
Analysis o f diffusivity estimates for the core and wall membrane from fitting the 
diffusion model to experimental data on the release o f dextran from microcapsules over
ii
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time revealed that only layer thickness had an effect on diffusivity in the core. The 
diffusivity for four layers was almost half of that for two layers o f polyelectrolytes in the 
wall membrane. In the case o f diffusivity in the microcapsule wall, both time and layer 
thickness had an effect. Diffusivity was larger for two layers of wall membrane thickness 
than for four or six layers and it was also larger for 12 hours than for 36 or 60 hours of 
loading time. There was no significant change in diffusivity beyond four layers or 
beyond 36 hours o f loading time. In all cases, diffusivity in the wall membrane was 
considerably less than that in the core.
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
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CHAPTER 1
INTRODUCTION
1.1 General Overview
Microcapsules are hollow microspheres encapsulated by multilayers of 
polyelectrolytes. Considerable number o f studies has been done on microcapsules 
because o f its wide application. There are many applications of microcapsules in 
chemical, biomedical, and medical research. Interestingly they can also be used in many 
other areas, such as agriculture, the environment, and the automotive industry.
Various techniques and methods have been utilized in the manufacturing and 
applications o f microcapsules. O f interest is to determine the factors that affect the size 
o f a microcapsule during the manufacturing process as well as its characteristics for a 
given application process so that one can optimize both processes.
1.2 Research Objectives
Layer-by-layer adsorption o f oppositely charged polyelectrolytes, poly 
(styrenesulfonate) PSS and poly (allylamine) PAH, is used as an encapsulating technique 
in the manufacturing o f microcapsules. By using this kind of self-assembly technique, 
generated microsphere core material can be encapsulated with PSS or PAH multilayers
1
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2after which the core is dissolved to obtain the hollow microcapsules. In order to study the 
release properties, the hollow microcapsules are loaded with fluorescein-isothiocyanate 
(FITC) labeled dextran o f different molecular weights for different lengths o f time, and 
then immersed into water where the concentration of dextran is measured over time. .
Generating cores o f a certain homogeneous size and shape that can be dissolved 
after encapsulation is essential for the building of the microcapsules. Also, understanding 
the diffusion properties o f the microcapsule is important for its use in controlled release 
studies for drug delivery. Hence, the objectives o f this dissertation are two fold. First, to 
model the generation o f alginate droplets or cores using Computational Fluid Dynamics 
(CFD) methodology in order to determine the parameters necessary for optimizing 
droplet size and for minimizing its variance. Second, to model the diffusion properties of 
microcapsules using a 3-D diffusion model in spherical coordinates and to apply the 
model to experimental observations on dextran release in order to estimate the diffusion 
coefficients in the core and wall o f the microcapsules. This enables one to determine how 
diffusion relates to microcapsule characteristics such as wall thickness, polyelectrolyte 
type, loading time o f dextran into the microcapsule, and the molecular weight o f dextran.
1.3 Organization
Chapter One presents a brief introduction o f microcapsules and the research 
objectives. Chapter Two gives a literature review of microcapsules, droplets or cores 
generation o f microcapsules, and release studies o f microcapsules. Chapter Three 
introduces the experimental procedure of droplet generation and describes the model of 
droplet generation, the Computational Fluid Dynamics theory behind it. Chapter Four 
describes results and the statistical method to optimize the simulation results. Chapter
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
3Five introduces the experimental procedure of transport phenomena, the model o f release 
study, applied numerical analysis and model-checking methodology. Chapter Six 
describes simulation results and discussion.
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CHAPTER 2
LITERATURE REVIEW
2.1 Microcapsules
A microcapsule is generally composed o f a core material encapsulated by shell 
material that acts as a microcapsule wall. Microencapsulation is a very useful technique 
because of the semi-permeability o f the microcapsule wall. The wall can protect the inner 
material from the outer environment or can control its release. Microcapsules play an 
important role in chemical, biomedical, and medical research. O f importance is their 
potential use as bio-sensors, microreactors, microcarriers or as drug delivery vehicles 
(Tong, 2006; Chen, 2006). For instance, Ghan (2004) used polyelectrolyte microcapsules 
as reactors for synthesizing bio-polymers. Sun et al. (2003) used an ultra thin shell to 
encapsulate hepatocytes and showed that the obtained microcapsules had enhanced 
differentiated functions over cells cultured in monolayers. Microcapsules can be used 
also in many other areas such as bioremediation o f ground water and soil, herbicides, 
insecticides, fertilizers (Shigemi and Yoshikawa, 1994), air bag applications in 
automotive, bath salt fragrance in cosmetic and personal care, and even sunscreen 
products containing said microcapsules (Lahmani, 1996).
Because o f their wide applications, considerable research in science and 
engineering has been devoted to microcapsules. Thanks to the technique of layer-by-layer
4
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assembly of oppositely charged polyelectrolytes (Lvov, 1993; Hong, 1993; Decher, 1997; 
Sukhorukov, 2000; Lvov, 2001; Tong, 2006), multilayer microcapsules prepared by self- 
assembly onto removable colloidal particles have generated considerable scientific 
interest. These hollow capsules have shown potential applications as drug delivery 
vehicle, biosensors, microreactors, and microcarriers.
2.2 Droplet Generation
2.2.1 Microfluidic Devices
Because certain fluid properties, such as surface tension, wall adhesion, and 
energy dissipation, dominate at the microlevel, microfluidic devices are finding 
increasing applications as analytic systems, biomedical devices, tools for chemistry and 
biochemistry, and systems for fundamental research (McDonald, 2000; Thorson, 2001; 
Thwar, 2005). A microfluidic system was designed and fabricated by Prevot et al. (2003) 
to study the behavior o f polyelectrolyte microcapsules flowing in microchannels. 
Microfluidic devices were etched in glass and silicon by using conventional methods and 
equipments (McDonald, 2000). Conventional equipments have a disadvantage in the 
sense that turbulence cannot be controlled or generated consistently throughout the 
volume of the liquid. Hence, compared with conventional methods and processes, 
microfluidic devices show superior performance. In this dissertation, a microfluidic 
device (capillary system) is utilized to generate alginate microdroplets.
2.2.2 Methodologies
Microdroplets are prepared by various processes. Before the wide use of 
microchannels, microdroplets were generated through a microporous membrane and jet 
pinch-off. In membrane emulsification, the droplets are formed through the pores at the
5
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surface of the membrane because of the inner and outer stress difference. Pore size o f the 
membrane, pressure of the disperse phase, and adsorption kinetics o f the emulsifier 
influence the results of emulsification (Schroder, 1998). Caused by the interfacial tension 
between two immiscible phases, microdroplets are generated by jet pinch-off technology. 
Variables include nozzle size, flow rate, and type and concentration of the phases 
(Meister, 1969; Skelland; 1989; Webster, 2001). A microcapsule generating system 
containing an air knife was used to form spherical microcapsules containing tissue or 
living cells (Dorian, 1996; Dorian, 1996). A vibrating orifice aerosol generator (VOAG) 
was used by Ray et al. (2005) to generate droplets with a small size variation. The 
droplets were dispersed in air to prevent agglomeration. The generation o f tailored 
microspheres can be achieved using this technique. These particles are microspheres of 
polymeric materials manufactured by in-situ photopolymerization of droplets containing 
monomers and additives. The important factors using this technique are: the pressure 
used to generate monodisperse droplets through a VOAG, the vibration frequency o f the 
orifice, the surrounding gas temperature, and the dispersion air.
Recently, microchannels have been used for generating microdroplets in 
microfluidic devices. Emulsions are formed by shearing one liquid into another 
immiscible liquid, often in the presence o f a surfactant, to create small droplets. These 
droplets are formed by forces generated at the leading edge of the two liquid phases. 
Results of the emulsification process can be described by the mean droplet size and the 
variance of the droplet size. Among other parameters, flow rates of the two phases, 
viscosity o f the two phases, and geometry of the microchannel can influence the 
emulsification significantly (Lister, 1998; Thorson, 2001; Tan, 2004). Droplets formed
6
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by the co-flow of oil and water through a T-shaped microchannel have been studied by 
several groups (Thorson, 2001; Collins, 2003). Droplet generation has been studied in Dr. 
Palmer’s Laboratory at Louisiana Tech University. They used a T-shaped channel 
microfluidic device with a bifurcating junction to generate alginate droplets. Alginate is 
sheared by a continuing phase, vegetable oil.
2.2.3 Alginate Microdroplets
Alginate, used in the generation of microdroplets or spheres, is derived from 
seaweed which is a salt o f alginic acid. Alginate is widely used in many areas because of 
its mild gelling, biocompatibility, and biodegradability. For instance, alginate is the most 
popular material for the formation of the polymer matrix and outer biocompatible 
membrane. Purified alginate was used to coat cell or tissue transplants (Dorian, 1996). 
Sodium alginate can be used in the food industry as an emulsifier, thickener, stabilizer, or 
gel-forming agent like agar and carrageenan (Ragaza, 1999). Wheatley (1991) attempted 
to form microparticles from sodium alginate in a 1/3 % buffered calcium chloride 
solution. Also, sodium alginate-chitosan (AC) microcapsules were used by Yu (2006) as 
immobilization carriers for cell culture. Ma et al. (2005) provided a method for preparing 
sodium alginate-polylysine microcapsules which contain immobilized yeast cells. 
Calcium alginate is a traditional method to fix bone splitters. As a general therapy, 
calcium alginate is administered as a nutrient additive 1-2 times a day in addition to diet. 
Orive et al. (2006) created alginate-PLL-alginate (APA) microcapsules using an 
electrostatic droplet generator. The alginate-poly-L-lysine-alginate membrane is widely 
used in cell encapsulation. Chen (2006) successfully used these APA microcapsules to 
limit the major immuno-rejection problems related to the use of live cells and bacteria in
7
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some animal models. Li et al. (2005) attempted to evaluate the function of porcine islets 
encapsulated by APA. APA microencapsulated porcine islets were able to secrete insulin 
both in vitro and under a perfusion condition. The porcine islets showed the ability to 
secrete insulin in a culture medium of different glucose concentrations. It was shown that 
both in vitro and in vivo APA microencapsulated porcine islets can maintain their 
function and therapeutic effect. Sun et al. (2002) used an electrostatic droplet generator 
(EDG) technique to prepare APA microcapsules and study the thickness o f the 
polyelectrolyte APA microcapsule membrane. Glucose oxidase-doped alginate 
microspheres encapsulated with calcium chloride added for ionic gelation were produced 
for enzymic sensors using water-in-oil emulsion (McShane, 2005). Monodisperse 
calcium alginate microparticles were studied in this research. These microcapsules can be 
used as vehicles to carry sensing material into the human body. The optimum size o f the 
microparticles for implanting in the transderma layer was about 40-50 pm.
2.3 Laver-bv-laver Encapsulation
Microcapsules prepared by the deposition o f alternate layers o f crosslinked 
atelocollagen and polyholosides are biocompatible by virtue o f the presence of 
atelocollagen. Atelocollagen with a very low antigenicity and a perfect biodegradability 
has most o f the advantageous properties o f collagen (Levy, 1997). Ijichi (1997) was 
successful in obtaining spherical gelatine/acacia microcapsules with thicker membrane by 
using the conventional complex coacervation method. Double layered microcapsules 
were made by Yamamoto and Sefton (1996) using vinyl amine copolymer films. Those 
microcapsules can perform polymer grafting reactions without damaging cells inside the
8
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microcapsules. Takiguchi et al. (2004) developed technology for discharging and
microencapsulating minute amounts of droplets.
Polyelectrolyte multilayer microcapsules are microcapsules with the walls made 
of polyelectrolyte multilayers. Layer-by-layer assembly o f oppositely charged 
polyelectrolyte onto removable colloidal particle surfaces has been used by many groups 
because of its potential application (Radtchenko, 2000; Antipov, 2002; Tong, 2006). 
Voigt (1999) reported on the use o f nonsol. Polystyrene sulfate latex, solution melamine 
formaldehyde resin latex, and decomposable glutaraldehyde-fixed human red blood cells 
as target particles for layer-by-layer adsorption. Zhao et al. (2006) and Gao et al. (2006) 
showed how the structure and stability o f polypeptide multilayer films can affect various 
types o f noncovalent interactors. Rilling et al. (1997) used polycation/polyanion double 
layers to encapsulate cytochrome C. The layer-by-layer assembly technique was used to 
construct various types o f POM-polyelectrolyte composite microcapsules because o f the 
versatile properties o f polyoxometalate (POM) (Gao, 2005). For the layer-by-layer self­
assembled polyelectrolyte microcapsules, a magnetic field can be used to modulate the 
permeability (Lu, 2005; Prouty, 2004).
At the Institute for Micromanufacturing (IFM), Louisiana Tech University, poly 
(styrene sulfonate) (PSS) and poly (allylamine) (PAH) are the two polyelectrolytes used 
in layer-by-layer encapsulation o f microsphere colloidal core material (melamine formal 
dehyde (MF)) to obtain multilayer microcapsules. Pargaonkar (2005) showed that the 
release phenomena can be controlled by the component and the number o f layers. A 
composition o f a sustained release layer and a fast release layer was also used in order to 
optimize microcapsules for controlled release.
9
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2.4 Transport Phenomena
“The main focus in the area o f emulsion technology is to improve stability and 
control the release o f active matter in double emulsions” (Lyon, 2002). Because of the 
permeability property o f a microcapsule’s wall, microencapsulation is an important 
technique used to protect the inner materials from the outer environment or to control the 
release of the encapsulated inner materials. Studies o f mass transport in microcapsules 
are important for microcapsule applications. Microcapsules have potential applications in 
drug delivery, as biosensors, microreactors, or microcarriers.
Setterstrom et al. (1982) developed microcapsules that can maintain slow release 
o f effective therapeutic doses o f antibiotics in a wound over a 14-day period. Polk 
(1994) used semi-permeable biocompatible microcapsules to entrap a vaccine in order to 
destruct the fish digestive system. It was showed that controlled-release formulations can 
provide a short half-life “pulsed” plasma profile o f a sedative-hypnotic compound. 
Research on anticancer drug doxorubicin hydrochloride (DOX) in a drug delivery system 
was undertaken by Yang et al. (2005), Khopade et al. (2002), and Liu et al. (2005). 
Benichou et al. (2004) attempted to select food-grade blends of emulsifiers to enhance 
emulsion stability at both inner and outer interfaces. They used new polymeric 
amphiphiles (carriers, complexing agents, natural polymeric emulsifiers) in order to 
control and reduce the reverse micellar transport phenomena and to control the transport 
the inventive method and associated device was used by Windhab (2005) to obtain multi­
microcapsules. These microcapsules are adapted to different substance components and 
release conditions.
In so many applications o f microcapsules, a critical question is how to control the 
transport phenomena. From research in the literature, it is clear that the permeability o f a
10
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microcapsule depends on the type and thickness of the wall, loading time of the inner 
material, pH value, temperature, and molecular weight o f the inner material (Takagishi, 
1994; Antipov, 2002; Kim, 2004; Yang, 2005; Pargaonkar, 2005; Windhab, 2005; Tong, 
2006). To determine how these factors can influence the transport phenomena, it is 
necessary to develop a theoretical model. The determination o f the mass transfer 
coefficient value yields clear insight into the characterization of microcapsules with semi- 
permeable membranes (Lewinska, 2002; Rosinski, 2005). Due to the semipermeability of 
the capsule wall, Tong (2006) created a Donnan equilibrium between the inner solution 
within the capsules and the bulk solution. Kwok et al. (1991) developed a general 
diffusion model for alginate-polylysine (PLL) microcapsules which can describe mass 
transport phenomena and membrane diffusivities. The apparent size o f the impermeable 
gel core and the capsule membrane permeability were used to describe the results. 
Factors that can affect the results are the size o f the diffusing protein and the alginate- 
PLL reaction time. These microcapsules can be used in cell culture engineering and cell 
transplantation by affecting cell viability. Manca et al. (2003) modeled the release 
process within the human body. In that model, they showed how polymer coating can 
affect the transport phenomena.
11
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CHAPTER 3
DROPLET GENERATION MODEL
3.1 Introduction
For application purposes, it is desirable to produce alginate microspheres in the 
range o f 40-50 pm in diameter. Such capsules have been produced in Dr. Palmer’s 
laboratory at Louisiana Tech University using alginate and vegetable oil as the 
immiscible phase. Before the wide use o f microchannels, microparticles were generated 
through a microporous membrane and jet pinch-off. The microchannel technique 
involves the use o f a T-shaped channel micro fluidic device with a bifurcating junction 
(Figure 3.1) which allows for the mixing o f the two immiscible phases, alginate and 
vegetable oil.
Figure 3.1. Enlarged T-shaped channel
12
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The alginate microparticles are produced due to the interfacial tension (or force) 
generated between the two immiscible phases. When alginate molecules at the interface 
are subjected to this interfacial force, they rearrange themselves in order to reduce this 
exerted force. This rearrangement is in the form of a spherical configuration since this 
reduces the surface area and produces the least strain on the system.
3.2 Experimental Procedure
The experimental setup is shown in Figure 3.2. The critical components are 
labeled in the diagram.
Vegetable 
oil pump
Vegetable 
oil source
^Droplet
generator
Alginate
pump
lginate
source
T shaped 
channel
Figure 3.2. Experimental setup
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3.2.1 Preparation of the Two Phases
Calcium chloride solution: 10% wt o f calcium chloride is made by adding 50 g of 
calcium chloride into 500 g o f water.
Alginate solution: 2% wt alginate solution is made by adding 4 mg o f FITC 
dextran and 0.6 g o f sodium alginate into 30 g o f water.
3.2.2 Process
Alginate and calcium chloride solutions are inputed into the system at the same 
time. After the flows are stabilized, the alginate particles sheared by the calcium chloride 
flow are sent into the CSTR containing the calcium chloride solution which is under 
constant stirring (over head stirrer). Alginate spheres tend to coagulate at the inter phase 
surfactants. In order to prevent coagulation, Tween 80 (2%v/v) and Span 80 (1.5%v/v) 
are added to tlje dispersed and the continuous phase.
3.3 Mathematical Model
Droplets are generated by the imbalance between the interfacial tension and the 
Laplace pressure. Alginate molecules arrange themselves into microspheres in order to 
reduce the tension by reducing their interfacial area. A spherical configuration minimizes 
the stain on the system.
FLUENT, a computational fluid dynamics (CFD) software, can be used to 
simulate complex engineering problems. We can use FLUENT to model droplet or 
microcapsule generation. The model can be verified by comparing predicted values to 
experimental results. A model that can accurately simulate the process o f droplet 
generation would be useful for planning and design o f experiments and for reducing 
experimental time and cost.
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The model chosen in FLUENT for droplet generation is the volume of fluid 
(VOF) model. The VOF model can simulate the behavior o f two immiscible fluids by 
solving the momentum equation in each cell and tracking the volume fraction o f each 
fluid throughout the domain. The volume fraction of the phase in the computational cell 
is introduced as a variable for each phase in the model. The volume fractions o f all 
phases sum to unity in each cell. The whole domain is meshed into a large number of 
cells. For two phases, let a q stand for the qXh fluid volume fraction (q = 1,2) in a cell. It 
is seen that
1. a  = 0 implies that the cell is empty of the qih. fluid.
2. a q = 1 implies that the cell is full of the qXh. fluid.
3. 0 < a q< \  implies that the cell contains both the qXh fluid and the other
fluid. A cell that conatins both fluids is at the interface.
The solution of the continuity equation, Equation 3.1, for the volume fraction is 
used for the tracking o f the interfaces between the two phases.
da
— + v- V a  = 0
d t
(3.1)
In Equation 3.1, a q stands for the ^th fluid’s volume fraction in the cell,
v stands for velocity vector o f the fluid in the cell, and
t stands for time.
All phases in each cell sum to unity,
n
(3.2)
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Thus, the density and viscosity in a given cell can be evaluated as weighted means 
of the densities and viscosities o f the individual phases. The weights are the volume 
fraction o f the phases. For instance, one can use the following equations to represent the 
density and viscosity in each cell:
P = » (3-3)
where p  stands for the density in the cell,
a q stands for the qXh fluid’s volume fraction, and 
p q stands for the density o f the q\h fluid.
Also,
P^Yua<iPq (3-4)
where p  stands for the viscosity in the cell,
a q stands for the ^th fluid’s volume fraction, and 
p q stands for the viscosity o f the qih. fluid.
The properties p  and p  depend on the volume fractions o f all phases. Therefore, 
the momentum equation in a cell, in which p and //a re  included, is dependent on the 
volume fractions o f all phases. The VOF model simulates the process by solving a set o f 
momentum equations over cells and tracking the volume fraction o f all the phases 
throughout the domain. As such, p  and p  are the connection between the momentum 
equation and the volume fractions o f the two phases.
The 2-D continuity equation used in this model is
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where p  is the density,
v is the velocity vector for the two fluids.
Momentum is a vector quantity. It is based on Newton’s second law of motion. 
This is expressed as
P  = mv (3.6)
Where P  stands for momentum,
v stands for velocity of the fluid in the cell, and 
m stands for mass o f the fluid in the cell 
Dividing the left and right hand sides of Equation 3.6 by time t, one obtains the 
following equation:
(output -  input + accumulation) x rate o f momentum= , (3.7)
where F  is the force.
The momentum equation for every cell is:
— ( p v ) + V - ( p v  v) = -  V/>+V-[/i(Vv+Vv ) ] + p g + F ,  (3.8)
dt
Where t is time,
-»
v is the velocity o f the fluid in the cell, 
p  is the density in the cell,
p  stands for the pressure exerted on the fluid in the cell, 
p  stands for the viscosity in the cell,
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g  is the gravitational force exerted on the fluid in the cell, and
—»
F  is the friction force exerted on the fluid in the cell.
The first expression on the left hand side o f Equation 3.8 represents the increase 
in momentum. The second expression on the left hand side o f Equation 3.8 represents 
momentum input by convection. The first expression on the right hand side o f Equation 
3.8 represents the pressure force. The second expression on the right hand side o f 
Equation 3.8 represents momentum input by viscous forces. The third expression on the 
right hand side o f Equation 3.8 represents gravitational force. The fourth expression on 
the right hand side o f Equation 3.8 represents friction force.
The boundary conditions and initial conditions for the momentum equation are:
Boundary conditions:
Alginate input and vegetable oil input are defined as velocity inlet boundaries 
describing flow entering the physical domain o f the model. FLUENT uses the velocity 
inlets boundary conditions to compute the mass flow into the domain through the inlets 
and to compute the fluxes o f momentum, energy, and species through the inlets. The 
mass flow rate entering a fluid cell adjacent to a velocity inlet boundary is computed as
m = ^ p v - d  A ,  (3.9)
where m stands for the mass flux,
p  stands for the density in the cell,
—>
v stands for velocity o f the fluid in the cell, and 
A stands for the area.
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The oil/alginate interface boundary is computed as
mi -  Jp v  - d A t - p Q i  (3.10)
where w, stands for the mass flux going through the interface area 
—►
Ai stands for the interface area 
Q, volume o f fluid
The output boundary is defined as the outlet pressure. FLUENT uses condition 
pressure as the static pressure o f the fluid at the outlet plane, and all other conditions are 
extrapolated from the interior of the domain.
The boundary condition at the wall is a fixed heat flux o f zero. Walls are 
stationary and shear condition at the wall is no slip.
Initial conditions:
va = Vj, at the alginate input interface
va - 0 ,  otherwise
va = v2, at the vegetable oil input interface 
vc = 0 , otherwise,
where va stands for the velocity o f alginate,
v0 stands for the velocity o f vegetable oil, and 
v, and v2 stand for the constants.
It is seen that the momentum equation Equation 3.8 and volume fraction equation 
Equation 3.1 are coupled equations. The velocity in Equation 3.1 is obtained from the 
solution o f Equation 3.8. Also, the solution to the momentum equation depends on p  and
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//w hich in turn depend on the knowledge o f the volume fraction from Equation 3.1. 
Hence, the VOF model simulates the process through a simultaneous solution o f Eqs. 3.8 
and 3.1.
3.4 Simulation
FLUENT, as a powerful CFD software, is used in this research to simulate the 
droplet generation process. The volume o f fluid (VOF) model was chosen because it can 
model two immiscible fluids by solving a set o f momentum equations and tracking the 
volume fraction o f each of the fluids throughout the domain.
The simulation process includes the following steps:
• Designing the geometry of the channel
• Setting up the model
• Running the model
• Evaluating the results
3.4.1 Designing the Geometry 
of the Channel
Gambit 2.1 as the preprocessor for FLUENT is used to design the geometry of 
the channel. There are three main steps in the design of the geometry.
•  Draw a 2-dimensional area to represent the channel. To draw the area, one 
needs to locate all the points by specifying x and y coordinates, join the 
points to obtain the sides (boundaries), and then connect all the sides 
together to get the 2-D area (Figure 3.3).
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Gx
Figure 3.3. Two-dimensional area o f the channel
• Mesh the 2-dimensional area (Figure 3.4), see the enlarged graph (Figure 
3.5). FLUENT operates on this area using the finite volume method.
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Figure 3.4. Two-D area mesh
- *= - *• -Hi-
Figure 3.5. Enlarged 2-D mesh
• Set the type o f boundaries. As is shown in Figure 3.6, a velocity inlet is set 
for the alginate input, two velocity inlets are set for vegetable oil input, 
and a pressure outlet is set for the output. The other boundaries are wall 
boundaries.
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Figure 3.6. Boundary types o f the channel sides
The design o f the channel geometry can be saved as a mesh file which 
includes the channel geometry and the boundary type information.
3.4.2 Setting up the Model
A mesh file is created by Gambit with all the information about channel 
geometry and boundary conditions. FLUENT will take the file over from Gambit to set 
up the model according to the following steps:
• Import the mesh file.
The mesh file created by Gambit is imported into FLUENT. The mesh file 
provides the geometry information. The next step is to specify the unit 
according to the experimental equipment shown in Figure 3.7.
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Figure 3.7. Scale grid
• Choose the solver and model.
The segregated solver is chosen. An implicit unsteady first order 
formulation is used in this solver. PRESTO! and PISO schemes are chosen for 
pressure and pressure-velocity coupling. The momentum scheme is the first 
order upwind. In order to specify the VOF model, one needs to set up the 
materials and phases.
• Materials and phases.
The two fluids, alginate and vegetable oil, are created by specifying the
density and viscosity properties o f the fluids. Vegetable oil is set to be the
primary phase and alginate the secondary phase. Interfacial tension between 
the primary phase and the secondary phase is set to be 1 because the two 
phases are immiscible.
• Boundary conditions:
The boundary conditions need to be specified for the VOF model. Walls 
are stationary and shear condition is no slip as default. Output is the pressure 
outlet satisfying PRESTO! and PISO schemes. The vegetable oil velocity inlet
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is the input o f the primary phase. So the phase for this boundary is the primary 
phase vegetable oil and the input velocity o f this phase is entered here. The 
alginate velocity inlet is the input o f the secondary phase. So the phase for this 
boundary has to be the secondary phase alginate and the input velocity o f this 
phase is entered here.
3.4.3 Running the Model
The above steps are all that is needed to set up the VOF model. To run this 
model, the setting of the initial conditions and iteration is required.
•  Initial conditions:
The initial velocity for all the cells is zero except for the boundaries of 
alginate input and vegetable oil input. The initial velocity o f alginate at the 
alginate input boundary is entered here and the direction is along the x axis. 
The initial velocity o f vegetable oil at the vegetable oil input boundary is 
entered and the direction is along the y axis.
•  Iteration:
In this step, the time step and the number of sub-steps are specified. The 
time step is the maximum interval which can guarantee convergence and 
shorten the simulation time.
3.4.4 Parallel Computing on 
a Linux Cluster
FLUENT can work efficiently on a PC for small problems. For big problems, 
like the droplet simulation in this paper, we used parallel computing on a cluster to 
reduce calculation time. Cluster computing was considerably faster than the PC. Parallel 
computing is widely used in the scientific computing and engineering analysis
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communities. The idea is to connect several computers together to solve a single problem 
using their collective power. A multi-processor FLUENT job is launched from a “host 
node.” A graphical user interface (GUI) is run on the host node. Using the Putty (a 
telnet/SSH client) and Cygwin (Linux-like environment for Windows), FLUENT on the 
cluster can be run on any PC as a terminal.
Figure 3.8 shows how the idea works in FLUENT, the communication 
between all nodes represents passing messages.
H m ! N rnl?  
H. UF NI  t . f u r u h  
R U F N ' f  CUf 
ContfHrtr- N o d i1 0
Figure 3.8. Running FLUENT on a cluster
It is seen from Figure 3.8 that all the nodes can run in parallel. This can reduce 
the turn-around time in computation. As is shown in Figure 3.9, computation speed as a 
function o f project size increases with an increase in the number o f processors in the 
cluster.
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Figure 3.9. Parallel computing performances o f different number o f processors
Figure 3.9 represents three size groups. The droplet simulation project has 
300,007 cells, which belongs to the larger size group. As such, performance was 
dramatically improved by parallel computing. Fourteen processors were used in the 
simulation because o f the limitation o f the license Louisiana Tech University purchased.
3.4.5 Evaluating the Results
The volume fraction distribution o f the secondary phase (alginate) is captured 
in graphical mode every time step. All the graphs are connected into a video to show how 
alginate is sheared by the vegetable oil flow. The droplet size and its variance can be used 
to describe the results. In Chapter 4, comparison o f the simulation results and 
experimental results is studied in detail.
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CHAPTER 4
RESULTS AND DISCUSSION OF 
DROPLET GENERATION
4.1 Introduction
This chapter deals with the simulation o f a two phase flow process in a 100 
micron width channel for the generation o f droplets. The geometry in Figure 3.3 is used 
with proper boundary conditions. Comparisons between the theoretical results from 
simulation and experimental results are presented.
4.2 Simulation Design
A factorial experiment at two levels with a center point (Table 4.1) was used in 
order to obtain an optimum factor combination that gave the desired particle size with 
minimum variance. The velocity of the vegetable oil and the velocity ratio o f vegetable 
oil to alginate were considered as the two quantitative continuous factors. The idea used 
is based on response surface methodology. It involves collecting observations at each 
location on a grid o f treatment combinations spanning the entire simulation region, and 
then estimating the response surface in the vicinity o f  the optimum response. Based on 
the responses obtained from the first design in Table 4.1, an optimum was selected and a 
second factorial experiment (Table 4.2) was run in the vicinity o f this optimum.
28
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Table 4.1. Simulation runs for different factor combinations
Vegetable
Oil Ratio
Model Coded Uncoded Coded Uncoded
Exp100-1 -1 0.05 -1 5
Ex p100-2 -1 0.05 1 25
Exp100-3 1 0.2 -1 5
Exp100-4 1 0.2 1 25
Exp100-5 0 0.125 0 15
Table 4.2. Simulation runs for different factor combinations in the vicinity o f an optimum 
droplet size and variance
Vegetable
Oil Ratio
Model Coded Uncoded Coded Uncoded
Exp100-11 -1 0.08 -1 8
Exp100-12 -1 0.08 1 12
Exp100-13 1 0.12 -1 8
Exp100-14 1 0.12 1 12
Exp100-15 0 0.1 0 10
4.3 Simulation Results
In running the simulation, the alginate volume fraction contours, as shown in 
Figure 4.1 were used to represent the alginate phase distribution which ranges from 1 
(red color) to 0 (blue color). For the runs in Table 4.1, Exp 100-1 and Exp 100-2 did not 
generate any droplets (Figures. 4.2 and 4.3a). This was attributed to the low velocity o f 
the vegetable oil. In Exp 100-3, alginate was distributed as a stream because o f the low 
ratio (Figure 4.3b). Particles or droplets were generated in the case o f the two runs, 
Exp 100-4 and Exp 100-5 (Figure 4.4 a, b). However, the particle size was too small in 
both of these runs, but in Exp 100-5, the particle size was much larger than in the case of 
Exp 100-4. As a result, the experimental runs in Table 4.2 were designed in a new region 
with center point at 0.1 m/s for the vegetable oil velocity and 10 for the ratio.
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Figure 4.1. Alginate volume fraction Figure 4.2. Exp 100-1 alginate volume
contours fraction contours
Figure 4.3. (a) Exp 100-2 and (b) Exp 100-3 alginate volume fraction contours
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Figure 4.4. (a) Expl00-4 and (b) ExplOO-5 alginate volume fraction contours
In ExplOO-11 and Expl00-13 o f Table 4.2, alginate was distributed as a stream 
because o f the low ratio (Figures 4.5a, 4.6a). Particles were produced in the cases o f 
Expl00-12 (Figure 4.5b), Expl00-14 (Figure 4.6b), and Expl00-15 (Figure 4.7). The 
Exp 100-15 run gave the largest particle size and the largest variance. The means and 
standard deviations for the short and long droplet diameters are presented in Table 4.3.
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Figure 4.5. (a) ExplOO-11 and (b) Expl00-12 alginate volume fraction contours
Figure 4.6. (a) Expl00-13 and (b) Expl00-14 alginate volume fraction contours
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Figure 4.7. Exp 100-15 alginate volume fraction contours
Table 4.3. Average and standard deviation for short and long particle droplet diameters 
for the different experimental runs
Case # Algina 
te flow 
rate 
(m/s)
Oil
flow
(m/s)
Ratio Average
short
particle
diameter
(pm)
Standard 
deviation 
of short 
diameter
Average
long
particle
diameter
(pm)
Standard 
deviation of 
long 
diameter
Exp100-11 0.01 0.08 8 No D.F.
Exp100-12 0.0067 0.08 12 21.7 8.1 25.1 8.6
Exp100-13 0.015 0.12 8 No D.F.
Exp100-14 0.01 0.12 12 22.9 7.2 24.8 8.5
Exp100-15 0.01 0.1 10 22.7 11.3 26.9 17.5
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4.4 Results
As it is shown in Table 4.3, the coefficient o f variation (standard deviation/mean) 
o f the short diameter ranges from 0.314 to 0.498 and that o f the long diameter ranges 
from 0.342 to 0.65. Expl00-15 has the largest coefficients o f variation (0.498 for the 
short diameter and 0.65 for the long diameter). Considering the mean and coefficient of 
variation for droplet size, it would seem that the factor combination in Exp 100-14 gives a 
relatively large mean diameter and small coefficient o f variation and is to be preferred to 
the other experimental runs.
For all the simulation in this study, the following properties for oil and alginate 
were used.
Olive oil: Density 930 kg/m3
Viscosity 0.03 kg/m-s 
Alginate: Density 1012 kg/m3
Viscosity 0.21372 kg/m-s 
In order to determine if changing the properties would decrease the variance from 
that observed in Table 4.3, we changed, for simulation purpose, the properties o f oil and 
alginate as follows:
Olive oil: Density 918 kg/m3
Viscosity 0.084 kg/m-s 
Alginate: Density 998.2 kg/m3
Viscosity 0.001003 kg/m-s 
The biggest change was in the viscosity o f alginate which made it closer to water. 
Run Exp 100-16 represented the low viscosity o f alginate. Comparisons o f  the mean and
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standard deviation for Exp 100-15 and Exp 100-16 show that the means are almost the 
same, but the variance for the low viscosity (Exp 100-16 run) was much smaller than that 
for Exp 100-15. The variance changed from 11.3 to 7.97 for the short diameter and from
17.5 to 9.18 for the long diameter. It should be noted that since density and viscosity for 
oil and alginate are what they are, changing the viscosity or density for simulation 
purposes would imply that in practice one should use other materials for generating a 
droplet size with low variance or coefficient o f variation.
Figure 4.8. (a) Expl00-15 and (b) Expl00-16 alginate volume fraction contours.
4.5 Future Work
In this research, the velocity and ratio were considered as two factors. One can 
obtain the desired particle size by adjusting these two factors affecting the size o f 
generated microcapsules. Also, it was observed that the properties o f the two immiscible 
phases can influence the variance. In all the above simulations, the channel was straight 
with the width fixed at 100 micrometers. In future work, it would be o f interest to
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determine if  channel width and or geometry will have any effect on droplet size and 
variance.
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CHAPTER 5
MODELING OF TRANSPORT PHENOMENA
5.1 Introduction
“The main focus in the area o f emulsion technology is to improve stability and 
control the release o f active matter in double emulsions” (Lyon, 2002). Because o f the 
permeability property o f a microcapsule’s wall, microencapsulation is an important 
technique used to protect the inner materials from the outer materials or to control the 
release o f the encapsulated inner materials. In so many applications o f microcapsules, a 
critical question is how to control the transport phenomena. To develop a theoretical 
model, it is necessary to determine how different factors can influence the transport 
phenomena. These factors include type and thickness o f the wall, loading time o f the 
inner material, pH value, temperature, and molecular weight o f the inner material 
(Takagishi, 1994; Antipov, 2002; Kim, 2004; Yang, 2005; Pargaonkar, 2005; Windhab, 
2005; Tong, 2006).
Due to the semipermeability o f the capsule wall, Tong (2006) created a Donnan 
equilibrium between the inner solution within the capsules and the bulk solution. Kwok et 
al. (1991) developed a general diffusion model for alginate-polylysine (PLL) 
microcapsules which can describe mass transport phenomena and membrane diffusivities.
37
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In this chapter, the finite difference method is applied to model the transport 
phenomena of microcapsules.
5.2 Experimental Procedure
Layer-by-layer assembly o f oppositely charged polyelectrolyte onto removable 
colloidal particle surfaces has been used by many groups because o f its potential 
application (Radtchenko, 2000; Antipov, 2002; Tong, 2006). At the Institute for 
Micromanufacturing (IFM), Louisiana Tech University, poly (styrene sulfonate) (PSS), 
poly (vinylsulfat) (PVS), poly (allylamine) (PAH) and poly (diallyldimethylammonium 
chloride) (PDDA) are the four polyelectrolytes used in layer-by-layer encapsulation of 
microsphere colloidal core material (melamine formal dehyde (MF)) to obtain multilayer 
microcapsules.
5.2.1 Preparation of the Materials
Polyelectrolyte solutions: 1 mg/ml PSS or PAH with 20 mM of Tris-buffer and 
0.5 M NaCl.
Solvent solution: 0.1 MHCI.
Dextran solution: 0.15 mg/ml o f 4000MW FITC-dextran or 0.14 mg/ml o f 77,000 
MW FITC-dextran.
Core particles: melamine formaldehyde (MF) colloidal core particles o f 5.3 pm in 
diameter.
5.2.2 Process
•  Layer deposition: Polyelectrolyte PSS or PAH layer is deposited onto the 
MF core material by incubation for 15 min in the polyelectrolyte solution 
sequentially. After depositing every layer, the particles are washed three
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times in a 121 mM Tris-buffer solution and centrifuged at 6000 rpm for 5 
min to remove the wash.
• Dissolving the melamine formaldehyde core: A 0.1 MHCI solution is used 
to dissolve the core after depositing the desired layers. Centrifugation 
during the wash after core removal is performed at 3000 rpm for 8 min to 
minimize damage to the resultant shells.
• Loading dextran: 0.15 mg/ml o f 4000MW FITC-dextran or 0.14 mg/ml of 
77,000 MW FITC-dextran is loaded into the hollow microcapsules from 
the above procedure for 12, 36, and 60 h at a pH of 7. Seven washes are 
performed with 20 mM Tris-buffer to remove loosely associated FITC 
labeled dextran.
• Transport phenomena: The prepared FITC labeled dextran microcapsules 
are immersed into the mother-liquor (or bulk) to study the transport 
phenomena. A Quanta Master TM Model QM-2000-4 excitation/emission 
spectrofluorometer is used to quantify the concentration of FITC labeled 
dextran in the mother-liquor o f the sample.
5.3 Governing Equations
= ( 5 1 )
dt r 2 dr dr
where C stands for the concentration, 
t stands for the loading time,
Di stands for the ith diffusion coefficient, in the core (i=l), wall membrane 
(i=2), and bulk liquid (i=3),
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r stands for the radial distance from the center.
In this model, we assume that the core diffusion coefficient ( Z>, ) and the
membrane diffusion coefficient ( D2) and outside medium diffusion coefficient ( Z>3) are
constant and not a function of distance or time.
In all experiments, dextran was first allowed to diffuse into the microcapsules for 
a certain length o f time (loading period). After the loading was complete, the 
microcapsules were immersed in a water medium where dextran was released to the
outside. Both loading and release are transfer phenomena and can be simulated by the
diffusion model in Equation 5.1 with different initial and boundary conditions.
Loading Initial Conditions:
C(r,0) = 0 , 0 < r  < i?2 (5.2.1)
C(r,0) = Cout,R2 < r < R 3, (5.2.2)
where R2 stands for the radius of the microcapsule.
R3 stands for the radius o f the total area, microcapsule and outside
medium
C(r,0) stands for the concentration o f dextran at position r at time 0.
Cout stands for the concentration o f dextran in the outside medium and was 
equal to 0.14 mg/ml.
Initial conditions are the conditions at t = 0. So at time 0, the dextran 
concentrations in the core and in the membrane were 0. In the outside medium, the 
concentration was 0.14.
Loading Boundary Conditions:
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dr
(5.3.1)
(5.3.2)
C, = C2, r  = R} (5.3.3)
A (5.3.4)
C2 = C3,r -  R2 (5.3.5)
(5.3.6)
where C, stands for the dextran concentration in the core.
C2 stands for the dextran concentration in the membrane.
C3 stands for the dextran concentration in the outside medium.
D x, D 2, and D3 are the diffusion coefficients o f core material, membrane
and liquid bulk (outside medium).
Release Initial Conditions
where R2 stands for the radius o f the microcapsule.
C(r,0) stands for the concentration o f dextran at position r at time 0.
C(r,t)  stands for the concentration of dextran at position r at time t, 
where t is the loading time.
Initial conditions are the conditions at time 0. As is known from the experimental 
conditions, the microcapsules were loaded with dextran for a certain time, t. So the initial
C(r,0) = C(r , t ) ,  0 < r < R2 (5.4.1)
C(r,0) = 0,R2 < r  < R 3, (5.4.2)
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condition for the release process is C(r , t ) , which is the dextran concentration at position r 
at time t. C(r,t) is obtained from the diffusion model during loading time.
Release Boundary Conditions:
where Cx stands for the dextran concentration in the core.
C2 stands for the dextran concentration in the membrane.
C3 stands for the dextran concentration in the bulk.
D x,D 2, and D3are the diffusion coefficients o f core material, membrane
5.4.1 Fractional Crank- 
Nicholson Method
More and more scientific and engineering problems involve fractional calculus. 
Recently, Metzler et al. (1999), Barkai et al. (2000), Metzler et al. (2000) proposed a 
fractional Fokker-Planck equation to describe subdiffusive anomalous transport in the
(5.5.1)
(5.5.2)
C, -  C2, r  = R (5.5.3)
(5.5.4)
C2 = C3,r = R (5.5.5)
(5.5.6)
and bulk.
5.4 Calculation of Transport Phenomena 
Based on Governing Equations
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presence o f an external field. This equation becomes the fractional partial differential 
equation for the force-free case (Balakrishnan, 1985; Scalas et al., 2004; Metzler et al., 
2000; Schneider et al., 1988).
The Crank-Nicholson method is applied for solving the governing spherical finite 
difference equations. This method uses central differences rather than the forward 
difference o f the Euler method or the backward difference o f the backward Euler. The 
Crank-Nicholson method is also called the 5-point method. Every point is related to the 
adjacent five points as shown in Figure 5.1.
Figure 5.1. Five-point method
Cf . represents the dextran concentration at position i at time j. In the Crank-
Nicholson method, the calculation of a value at a given point depends on the five adjacent 
points.
Crank-Nicholson method:
Ci}
Q
r y+i C,
C:7+1,y+1
(5.6.1)
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where 0  is the weight factor,
If 0 = 1, Equation 5.6.1 gives rise to the fractional explicit method (Yuste et al., 
2003; Yuste et al., 2004).
If 0  is not equal to 1, the method is implicit.
If 0=0,  the method is fully implicit.
If 0=1/2, Equation 5.6.1 is the fractional Crank-Nicholson method.
For 0=1/2  and ji = ~ — , Equation 5.6.1 is re-written as follows:
5.4.2 Stability Analysis
It is known that the exact solution o f the differential equation can be expressed as 
a Fourier series. The Fourier mode o f the fractional Crank-Nicholson method is as 
follows:
X is called the amplification factor for the mode. This mode will be stable as long 
as (X)n is bounded as n —> <x>. In other words, 0 < X < -1  is the requirement if  the mode is 
to be stable. The diffusion coefficient D is larger than 0. As a result, X cannot be larger 
than 1. Since this is a three-region diffusion model, D has different values for different 
regions. Dmem stands for the diffusion coefficient o f the membrane. Dcore and Dout stand
y_i
(5.6.2)
n ik(jAx) (5.7.1)
where X -
l-2 Z )s in 2 —A:Ax 
 2 (5.7.2)
7 1l + 2Z)sin — kAx 
2
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for the diffusion coefficients in the core and bulk or outside solution. The diffusion 
coefficients in the core and bulk can be large enough to cause A to become negative, 
which leads to an unstable mode. In order to attain stability, the fully implicit scheme 
was used in the core and bulk regions.
5.4.3 Thomas Algorithm
Concentrations C at different positions at different times are the variables in 
Equation 5.6.2. C,-_, ■ , C,- ■, and CM j on the right hand side o f the equation are the 
concentrations at positions i-1, i, and i+1 at the previous time step j. We can consider 
these three variables as known. CM /+1, C, j+i , and CM j+l on the right hand o f the
equation are the concentrations at positions i-1, i, and i+1 at the new time step j+ l, 
which are considered as unknown. Equation 5.6.2 can be simplified as follows:
— h,CM, +1 + fl-C- -+1 — c-C-, ■ , = d i ,i = l, ,n
(5.8)c = c c =c'- 'o  J + l  '- 'l  J + l  » n-1 J + l n J+ l
Here, ai,bi,ci are the coefficients corresponding to Equation 5.6.2 andd i is a term 
related to C(._, .,Cf -.C^, ■. In other words, when the new time step i+1 is calculated, 
d t can be considered as known from the previous time step. For every three adjacent 
points, we can get an equation like Equation 5.8. So for all the n+1 points in the domain, 
we can get n-1 schemes like the above one. All the schemes can be written in matrix form 
as follows:
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1
1 1
_r
> '  r
U + i '  d x ~
(N01(N1 r 2,7 + 1 d 2
~b; ax c 1,7 + 1 - d t
-K-x an-i cn_x c n-1,7 + 1 d.-i
~ bn an- c n_ c_ n , j+ l _  d n
(5.9)
The usual approach to solve tridiagonal linear systems is the Thomas algorithm 
(William, 1941). The forward Thomas algorithm is shown as follows:
• When / = 1, Equation 5.8 is applied to give
— ^ i^oj+i + a\C\,j+\ ~ c\^2,j+\ = d\ (5.10.1)
At the boundary condition, Coj+x = C, /+1, so the terms are combined to give
Equation 5.10.2.
(«1 “ W j + i  ~ ciC2,j+i=dx (5.10.2)
Both sides are divided b y ^  -ft,)  to give
  d \ C
Cl,7+1 ~ + ---- lT '("2J+1 ~ f + e\C2Jj +1 (5.10.3)ax - b x ax-  bx
•  When / = 2, Equation 5.8 becomes
~  ^ 2 ^ 1 , j+ l  ^ a 2 ^ 2 , j + l  ~ C 2 ^ 3 J + l  =  d 2 (5.10.4)
Equation 5.10.4 is simplified by applying Equation 5.10.3 to obtain Equation
5.10.5.
r 2, j+ l 2 + Kfi  . 2 r  - f + e Ci z. 3./+1 J 2  2 3, j+ la2 -  b2ex a2 — b2ex
(5.10.5)
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• When i= l, , n, the general equation is
(5.10.6)
(5.10.7)
(5.10.8)
Using the same approach, the backward Thomas algorithm can be obtained. The 
general equation is as follows:
The algorithm introduced above is easy to use in a SIMD (Single Instruction, 
Multiple Data). A new parallel method was introduced by Dai (2000) for time saving. 
The problem can be decomposed into a number o f independent sub-problems and all the 
sub-problems can be preceded independently. Later on, the solutions o f all the 
independent sub-problems can be combined to obtain the solution o f the original 
problem. The parallel application for this research is shown as follows:
(5.10.9)
(5.10.10)
(5.10.11)
• 0 < r < Rx, the core material. The forward Thomas algorithm is applied as
in Equation 5.10.6. At the inside o f the membrane, the concentrations
satisfy the following conditions.
(5.11.1)
(5.11.2)
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Equations 5.11.1 and 5.11.2 are combined to eliminate the variableCR 1J+1. 
This gives
c , , , =  (|>- + 1 1 e„ , + 1) C , , f , , ( 5.11.3)
the liquid bulk. The backward Thomas algorithm is applied as in 
Equation 5.10.9. At the outside o f  the membrane, the concentrations need 
to satisfy the following conditions.
Cr2+\j+i = fl>n2+i + ebR^+lCR^ j +l (5.11.4)
A  (CR2j+, - C w l ) = D2{CR2+l- C Ri) (5.11.5)
Equations 5.11.4 and 5.11.5 are combined to obtain Equation 5.11.6.
C«. -u„ = - f - A . . .  (5.11.6)
.  R , < r  < R2, the membrane material. The following equations are applied 
in that region.
Of,+1J+1 =  f  R,+l~^ eRl+l^ 'Rl,j+i  ^Sr1+1^-'R2J+1 (5.11.7)
C r 2 - \ J + \  — f i ,R 2- i  T  e b R2 - \ ^ R 2 ,j+ \  T  S ^ >R1 - S - ' f l j . y+l  > ( 5 * 1  1 - ^ )
where ,eXi = 0  (5.11.9)
a R,+ 1 ^R i+ ie R,
j  =^,+i+ViA j  =0 (5.11.10)
aR,+l- b Ri+leRi
g*,+1= bR'+~*'h , g , ,=  1 (5.11.11)
a R l+ l ~ e R t b R l+ l
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2 \ - .  =  bR" X ~ >««, = 0  (5-1L12>
f l .S2 - l  CR 2- \ e R2
~  d R , +  C b  , /&„ ~
A 2-, = 2 2 '  2 >A ,  = 0  (5.11.13)
f l R2 - l  C R1- \ e )^R1
gb„. ,  =  ,*6„,= 1  (5.11.14)
a fl2 -1 6  ^ fi2 C« 2 -1
Equations 5.11.3, 5.11.6, 5.11.7 and 5.11.8 can be used to solve for 
C C*> -7+l and fl2 j,+1, which are used to calculate all the concentrations at any position at the 
new time step.
The parallel procedure is as follows:
• Calculate ei and fni = 0,....,RX, and calculate Equation 5.11.3.
C = ( —  + — e +1)C'- 'R ,+1,7+1 £ )  *1-1 '  * i J + l  £ )
• Calculate +1, +1 and +1 to obtain Equation 5.11.7.
^ R , +1,7+1 f  e R , + ^ R u j + \  & R i + \ C r 2 j +\
Calculate ebR x , f b R^ _x and gbRi_x to obtain Equation 5.11.8.
C r 2 -1,7+1 =  f l JR2- 1 +  e ^ R 2- \ ^ R 2 ,j+ \  +  S ^ >R 2 - \ ^ - 'R l , j+ l
Calculate eb{ and fb i , i = R2, N , and calculate Equation 5.11.6.
C r 2 -1,7+1 ~  ( p  e ^ R 2+ \ + ^ ) ^ R 2 J + \  p  f l >R 1+l
C CSolve for R"J+] and RlJ+' using the above four equations.
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• Calculate all concentrations at any position at the new time step using Eqs. 
5.11.1 and 5.11.4.
5.4.4 Inverse Problem
5.4.4.1 Introduction. Inverse analyses have many applications in various branches o f 
science and engineering such as that o f chemical engineering, geophysics and statistics. 
Difficulties arise with the implementation o f an inverse analysis. The main difficulty is 
that the inverse solution may not be unique, because it is very sensitive to the changes in 
input data resulting from measurement and modeling errors. Inverse problems cannot 
satisfy the general requirement o f existence, uniqueness, and stability under small 
changes in the data, so they belong to the ill-posed problems mathematically.
Inverse problems have attracted the interests o f many scientists and engineers. 
Many analytic and numerical approaches have applied to inverse problems. The Duhamel 
method was utilized by Stoltz (2004) to develop an analytic solution for a linear inverse 
heat conduction problem. As one o f the earliest investigators, Stoltz offered us a good 
insight into the problem. Stolz’s solution, however, was found to be unstable for small 
time steps. In the nonlinear case, the finite difference method (FDM) and the finite 
element method (FEM) were used to solve the inverse heat conduction problems (IHCP).
5.4.4.2 Inverse Solution
and Least Squares. In this research, a diffusion formulation and solution is
presented to simultaneously estimate the unknown diffusion coefficients. Because the 
inverse solution can minimize the least squares norm, the existence o f the inverse 
solution is guaranteed.
S { h  = f J[Yi - T i( p * ) f , j  = 1,2 (5.12.1)
1=1
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where Yt stands for the measured concentration,
A  A
T(Pj)  stands for the estimated concentration obtained from the solution 
o f the direct problem by using the estimated values o f the unknown parameters,
A
Pj stands for the elements o f the unknown parameter vector
A
p  -  {D, , D 2 } t , and Q stands for the total number o f the measurements.
The sum of squares can be minimized by differentiating it with respect to each of
A
the unknown parameters p  (j= l, 2) and then setting the resulting expression equal to 
zero.
a c  n p<rp A A
= 2 S ( ^ LXr.-(p)-J;) = o,; = i,2
8 P j  S p j
Equation 5.13.2 is written in matrix form as
^  = 2 X t( T - Y )  = 0,  
d p
~Ti' T
Ti y2where T  = I ,Y =
1
T. O-
Pi
A
Pi
A  V  d T, and X  = — zr
A  1
d p
dT]
A
dTx
d p , d p 2
dT2 dT2
dp i d p 2
d f a dTn
d p , d p 2
(5.12.2)
(5.12.3)
X is the sensitivity coefficient matrix with respect to p.
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5.4.4.3 Levenberg-Margguardt
Method. We can see that the system o f equations in Equation 5.12.3 is nonlinear,
so an iterative technique is required here to get the solution. The modified Levenberg- 
Marquardt (LM) algorithm, a combination o f the Newton method and the steepest 
descent method, can be used to solve the nonlinear least squares equations by iteration 
(Ozisik, 1993).
A  i + 1  A  4
p  = p  + ( J TJ  + p ki y ' J T( Y - T ) , k  = 1,2,3,.... (5.12.4)
A
where p  = {DVD 2}T = estimated parameter vector,
Y stands for the measured concentration, 
p k stands for damping parameters, and
J  = X  = the sensitivity coefficient matrix with respect to p.
The speed o f the Levenberg-Marquardt (LM) iterative least-squares method for 
the nonlinear problem depends upon the choice o f the damping parameters. To solve 
difficult problems efficiently, LM requires additive damping with small damping 
increments and large damping decrements, Lampton (1997).
5.4.4.4 The Solution Algorithm
with LM. The following is the solution algorithm with the LM method.
1. Solve Equation 5.1 with the FDM using the estimated values of
A  ^
P - { D v  A }  and compute T, the estimated concentration obtained from 
the solution o f the direct problem by using the estimated values o f the 
unknown parameters.
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4.
5.
6 .
Solve Equation 5.1 with the FDM two more times with different
parameters
T ( D X + A D , , D 2)
T  ( D | , D  j + A D 2)
Compute the sensitivity coefficients matrix J using the solution from 
step 1 and 2. For example, with respect to D, we have
dTt _ r(A + A D 1,p 2)- :r (A > A )
5D, AD,
Calculate ( J TJ  + j u j y 1 J T (Y - T )
A*+1
Calculate p
Restart from step 1 until the following criterion is satisfied
S k+X- S k
< \ E - 5
5.4.4.5 Check on the Diffusion Model. Mass balance was applied to check on the 
accuracy o f the diffusion model. The estimation o f core diffusivity and membrane 
diffusivity were obtained from the diffusion model. Using these estimates the total mass 
in the whole bulk area was calculated at different time steps. If the model is correct, one 
expects the total mass to remain constant over time. The Figure 5.1 is the total mass over
time when I sp ec ify ^  ~ 18.7/fln l h r ,D 2 = 5.9 x 10 pm I hr jt -s seen from Figure 5.2 
that, in fact, the total mass remains constant which indicates that the model is accurate.
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j 4 _ w  .  ■ f e ^ ^ a ^ i -: ^ g . 3 . ^ r , v  ■ * .  v ,  ■ i
Total Mass
Figure 5.2. Total mass in the bulk over time
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
CHAPTER 6
RESULTS AND DISCUSSION OF 
TRANSPORT PHENOMENA
6.1 Introduction
At the Institute for Micromanufacturing (IfM), Louisiana Tech University, poly 
(styrene sulfonate) (PSS), poly (vinylsulfat) (PVS), poly (allylamine) (PAH) and poly 
(diallyldimethylammonium) (PDDA) are the four polyelectrolytes used in layer-by-layer 
encapsulation o f microsphere colloidal core material (melamine formal dehyde (MF)) to 
obtain multilayer microcapsules. A permeability comparison for different layers of 
PSS/PAH, PVS/PAH, PSS/PDDA and PVS/PDDA was made using 4000 MW or 7700 
MW FITC-dextran loaded for 12h, 36h or 60h.
6.2 Comparisons of Experimental 
Data and Model Results
In fitting the model to the experimental observations, the radius o f the bulk liquid, 
R, was taken to be 18.6 fim. This was determined from the ratio o f the volume of the 
microcapsules in solution to the volume of the bulk solution. This ratio (estimated as 
0.002439 from experimental conditions) is equal to
55
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Ratio = —— ^—  ------  (6.1)
1 ^ ’ - V
3 3
where /??is the radius o f the microcapsule and is equal to 2 .5 / m .
Comparisons o f the experimental data and model results are shown in Figures. 
6.1-6.47. The experimental data are the normalized concentration o f dextran in the bulk 
liquid over time, recorded as the average o f three measurements. The model results are 
the predicted values from the finite difference release phenomena model. It is seen from 
these figures that, in general, there is a very good fit o f the model to the experimental 
observations.
The parameters D] and D2 were estimated from fitting the model to the 
experimental data. The parameter D3, is known and represents the diffusivity o f dextran
in water which was taken to be 6.28 x 105/ m 2 / h r .
Figure 6.1 shows that predicted (■) and observed (♦) normalized concentration o f 
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f 
PSS/PAH. Loading time=12h, MW=4000. Sum of square error, SSE=0.067.
psspah41240
0
s  1
|  0.8 
8 0.6 
|  0.4
|  0.2
1 o
0 20 40 60 80 100 120
tim e(h)
-|X
_ r r 5-
i *  v
♦  exp 
■ m odel
Figure 6 .1. Psspah41240 predicted and observed normalized concentration o f dextran
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Figure 6.2 shows that predicted (■) and observed (♦) normalized concentration o f
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PSS/PAH. Loading time=12h, MW=77000. Sum of square error, SSE=0.056.
p s s p a h 4 1 2 7 7
1.2
1
0.8■o .2 
_ 2 
s i 06
z  1 0 4
°  0.2 +
■ III*
1 1 * •
^7tT«r»T -r-r
♦  exp 
■ m odel
20  4 0  60  80  100
tim e(h )
120 140 160
Figure 6.2. Psspah41277 predicted and observed normalized concentration o f dextran
Figure 6.3 shows that predicted (■) and observed (♦) normalized concentration o f 
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f 
PSS/PAH. Loading time=36h, MW=4000. Sum o f square error, SSE=0.059625.
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Figure 6.3. Psspah43640 predicted and observed normalized concentration o f dextran
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Figure 6.4 shows that predicted (■) and observed (♦) normalized concentration o f
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PSS/PAH. Loading tim e^b h , MW-77000. Sum of square error, SSE=0.03471.
psspah43677
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Figure 6.4. Psspah43677 predicted and observed normalized concentration o f dextran
Figure 6.5 shows that predicted (■) and observed (♦) normalized concentration o f 
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f 
PSS/PAH. Loading time=60h, MW=4000. Sum o f square error, SSE=0.004871.
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Figure 6.5. Psspah46040 predicted and observed normalized concentration o f dextran
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Figure 6.6 shows that predicted (■) and observed (♦) normalized concentration o f
dextran released into the bulk liquid over time. Microcapsule wall is four layers of
PSS/PAH. Loading time=60h, MW=77000. Sum of square error, SSE=0.002657.
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Figure 6.6. Psspah46-77 predicted and observed normalized concentration o f dextran
Figure 6.7 shows that predicted (■) and observed (♦) normalized concentration o f 
dextran released into the bulk liquid over time. Microcapsule wall is four layers of 
PVS/PAH. Loading time=12h, MW=4000. Sum o f square error, SSE=0.007494.
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Figure 6.7. Pvspah41240 predicted and observed normalized concentration o f dextran
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Figure 6.8 shows that predicted (■) and observed (♦) normalized concentration o f
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PVS/PAH. Loading time=36h, MW=4000. Sum of square error, SSE=0.0757.
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Figure 6.8. Pvspah43640 predicted and observed normalized concentration o f dextran
Figure 6.9 shows that predicted (■) and observed (♦) normalized concentration o f 
dextran released into the bulk liquid over time. Microcapsule wall is four layers of 
PVS/PAH. Loading time=36h, MW=77000. Sum o f square error, SSE=0.002008.
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Figure 6.9. Pvspah43677 predicted and observed normalized concentration o f dextran
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Figure 6.10 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PVS/PAH. Loading time=60h, MW=4000. Sum o f square error, SSE=0.04956.
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Figure 6.10. Pvspah46040 predicted and observed normalized concentration o f dextran
Figure 6.11 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f 
PVS/PAH. Loading time=60h, MW=77000. Sum of square error, SSE=0.030535.
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Figure 6.11. Pvspah46077 predicted and observed normalized concentration o f dextran
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Figure 6.12 shows that predicted (■) and observed (♦) normalized concentration
of dextran released into the bulk liquid over time. Microcapsule wall is two layers o f
PSS/PDDA. Loading time=12h, MW=4000. Sum o f square error, SSE=0.00247.
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Figure 6.12. Psspdda41240 predicted and observed normalized concentration o f dextran
Figure 6.13 shows that predicted (■) and observed (♦) normalized concentration 
of dextran released into the bulk liquid over time. Microcapsule wall is two layers of 
PSS/PDDA. Loading time=36h, MW=4000. Sum o f square error, SSE=0.054048.
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Figure 6.13. Psspdda23640 predicted and observed normalized concentration of dextran
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Figure 6.14 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers o f
PSS/PDDA. Loading time=60h, MW=4000. Sum of square error, SSE=0.032675.
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Figure 6.14. Psspdda26040 predicted and observed normalized concentration o f dextran
Figure 6.15 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers of 
PSS/PDDA. Loading time=12h, MW=77000. Sum o f square error, SSE=0.018417.
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Figure 6.15. Psspdda21277 predicted and observed normalized concentration o f dextran
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Figure 6.16 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers of
PSS/PDDA. Loading time=36h, MW-77000. Sum o f square error, SSE=0.057577.
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Figure 6.16. Psspdda23677 predicted and observed normalized concentration o f dextran
Figure 6.17 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers o f 
PSS/PDDA. Loading time=60h, MW=77000. Sum of square error, SSE=0.049597.
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Figure 6.17. Psspdda26077 predicted and observed normalized concentration o f dextran
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Figure 6.18 shows that predicted (■) and observed (♦) normalized concentration
of dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PSS/PDDA. Loading time=12h, MW=4000. Sum o f square error, SSE=0.009251.
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Figure 6.18. Psspdda41240 predicted and observed normalized concentration o f dextran
Figure 6.19 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f 
PSS/PDDA. Loading time=36h, MW=4000. Sum o f square error, SSE=0.015766.
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Figure 6.19. Psspdda43640 predicted and observed normalized concentration o f dextran
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Figure 6.20 shows predicted (■) and observed (♦) normalized concentration o f
dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PSS/PDDA. Loading time=60h, MW=4000. Sum o f square error, SSE=0.238115.
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Figure 6 .20. Psspdda46040 predicted and observed normalized concentration o f dextran
Figure 6.21 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f 
PSS/PDDA. Loading time-12h, MW=77000. Sum of square error, SSE=0.014435.
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Figure 6.21. Psspdda41277 predicted and observed normalized concentration o f dextran
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Figure 6.22 shows that predicted (■) and observed (♦) normalized concentration
of dextran released into the bulk liquid over time. Microcapsule wall is four layers of
PSS/PDDA. Loading time=36h, MW=77000. Sum o f square error, SSE=0.012.
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Figure 6.22. Psspdda43677 predicted and observed normalized concentration o f dextran
Figure 6.23 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f 
PSS/PDDA. Loading time=60h, MW=77000. Sum of square error, SSE=0.026.
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Figure 6 .23. Psspdda46077 predicted and observed normalized concentration o f dextran
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Figure 6.24 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f
PSS/PDDA. Loading time=12h, MW=4000. Sum of square error, SSE=0.025808.
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Figure 6.24. Psspdda61240 predicted and observed normalized concentration o f dextran
Figure 6.25 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f 
PSS/PDDA. Loading time=36h, MW=4000. Sum o f square error, SSE=0.024.
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Figure 6.25. Psspdda63640 predicted and observed normalized concentration o f dextran
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Figure 6.26 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f
PSS/PDDA. Loading time=60h, MW=4000. Sum of square error, SSE=0.036.
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Figure 6.26. Psspdda66040 predicted and observed normalized concentration o f dextran
Figure 6.27 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers of 
PSS/PDDA. Loading time=12h, MW=77000. Sum o f square error, SSE=0.014997.
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Figure 6.27. Psspdda61277 predicted and observed normalized concentration o f dextran
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Figure 6.28 shows that predicted (■) and observed (♦) normalized concentration
of dextran released into the bulk liquid over time. Microcapsule wall is six layers of
PSS/PDDA. Loading time=36h, MW=77000. Sum of square error, SSE=0.034.
psspdda63677
g 12 
I 1 
| 0.8 
3 0.6
I 04| 0.2
£ 0
0  10 20  3 0  4 0  50
tim e (h )
-f..........  i....... .......  i------------------r-
♦  ex p  
■  m odel
Figure 6.28. Psspdda63677 predicted and observed normalized concentration o f dextran
Figure 6.29 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers of 
PSS/PDDA. Loading time=60h, MW=77000. Sum o f square error, SSE=0.36.
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Figure 6.29. Psspdda66077 predicted and observed normalized concentration o f dextran
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Figure 6.30 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers o f
PVS/PDDA. Loading time=12h, MW=4000. Sum of square error, SSE=0.010652.
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Figure 6.30. Pvspdda21240 predicted and observed normalized concentration o f dextran
Figure 6.31 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers of 
PVS/PDDA. Loading time=12h, MW=77000. Sum o f square error, SSE=0.065815.
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Figure 6.31. Pvspdda21277 predicted and observed normalized concentration o f dextran
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Figure 6.32 shows that predicted (■) and observed (♦) normalized concentration
of dextran released into the bulk liquid over time. Microcapsule wall is two layers o f
PVS/PDDA. Loading time=36h, MW=4000. Sum of square error, SSE-0.003324.
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Figure 6.32. Pvspdda23640 predicted and observed normalized concentration o f dextran
Figure 6.33 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers of 
PVS/PDDA. Loading time=36h, MW=77000. Sum o f square error, SSE=0.011105.
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Figure 6.33. Pvspdda23677 predicted and observed normalized concentration of dextran
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Figure 6.34 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers o f
PVS/PDDA. Loading time=60h, MW=4000. Sum of square error, SSE=0.015402.
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Figure 6.34. Pvspah26040 predicted and observed normalized concentration o f dextran
Figure 6.35 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is two layers o f 
PVS/PDDA. Loading time=60h, MW=77000. Sum o f square error, SSE=0.034494.
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Figure 6.35. Pvspdda26077 predicted and observed normalized concentration o f dextran
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Figure 6.36 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PVS/PDDA. Loading time=12h, MW=4000. Sum of square error, SSE=0.00472.
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Figure 6.36. Pvspdda41240 predicted and observed normalized concentration o f dextran
Figure 6.37 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f 
PVS/PDDA. Loading time=36h, MW=4000. Sum o f square error, SSE=0.004604.
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Figure 6.37. Pvspdda43640 predicted and observed normalized concentration o f dextran
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Figure 6.38 shows that predicted (■) and observed (♦) normalized concentration
of dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PVS/PDDA. Loading time=60h, MW=4000. Sum of square error, SSE=0.011997.
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Figure 6.38. Pvspdda46040 predicted and observed normalized concentration o f dextran
Figure 6.39 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f 
PVS/PDDA. Loading time=12h, MW=77000. Sum o f square error, SSE=0.022496.
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Figure 6.39. Pvspdda41277 predicted and observed normalized concentration o f dextran
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Figure 6.40 shows that predicted (■) and observed (♦) normalized concentration
of dextran released into the bulk liquid over time. Microcapsule wall is four layers o f
PVS/PDDA. Loading time=36h, MW=77000. Sum o f square error, SSE=0.014.
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Figure 6.40. Pvspdda43677 predicted and observed normalized concentration o f dextran
Figure 6.41 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is four layers o f 
PVS/PDDA. Loading time=60h, MW=77000. Sum of square error, SSE=0.003661.
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Figure 6.41. Pvspdda46077 predicted and observed normalized concentration o f dextran
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Figure 6.42 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers of
PVS/PDDA. Loading time=12h, MW=4000. Sum of square error, SSE=0.04102.
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Figure 6.42. Pvspdda61240 predicted and observed normalized concentration o f dextran
Figure 6.43 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f 
PVS/PDDA. Loading time=12h, MW=77000. Sum o f square error, SSE=0.013186.
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Figure 6.43. Pvspdda61277 predicted and observed normalized concentration o f dextran
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Figure 6.44 shows that predicted (■) and observed (♦) normalized concentration
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers of
PVS/PDDA. Loading time=36h, MW=4000. Sum of square error, SSE=0.008347.
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Figure 6.44. Pvspdda63640 predicted and observed normalized concentration o f dextran
Figure 6.45 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers o f 
PVS/PDDA. Loading time=36h, MW=77000. Sum o f square error, SSE=0.038904.
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Figure 6.45. Pvspdda63677 predicted and observed normalized concentration o f dextran
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Figure 6.46 shows that predicted (■) and observed (♦) normalized concentration
of dextran released into the bulk liquid over time. Microcapsule wall is six layers o f
PVS/PDDA. Loading time=60h, MW=4000. Sum o f square error, SSE=0.00288.
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Figure 6.46. Pvspdda66040 predicted and observed normalized concentration o f dextran
Figure 6.47 shows that predicted (■) and observed (♦) normalized concentration 
o f dextran released into the bulk liquid over time. Microcapsule wall is six layers of 
PVS/PDDA. Loading time=60h, MW=77000. Sum o f square error, SSE=0.022259.
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Figure 6.47. Pvspdda66077 predicted and observed normalized concentration o f dextran
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6.3 Estimates of Microcapsule Core and 
Wall Membrane Diffusion Coefficients
Estimates o f the diffusivity in the core o f the microcapsule (D l) and in the wall 
membrane (D2) were obtained from fitting the model to the experimental data as shown 
in Figures. 6.1-6.47. Table 6.1 gives these estimates for different types o f membranes, 
loading times, molecular weights, and layer thickness. The unit o f the diffusion 
coefficient (Dl and D2) is in ftm2 per hour.
Table 6.1. Estimates o f the diffusion coefficients in D l (the core o f the microcapsule) and 
in D2 (the wall membrane)
psspdda 21240 23640 26040 21277 23677 26077
D1 = 10.168659 24.8381887 18.562249 23.951496 24.900449 20.509278
D2= 1.64E-05 4.82E-06 4.20E-06 7.50 E-06 4.79E-06 3.53 E-06
SSE= 0.0024743 0.0540485 0.0326746 0.0184165 0.0575772 0.0495965
psspdda 41240 43640 46040 41277 43677 46077
D1 = 8.5991903 6.04202352 8.0807803 9.5221096 4.8 4.7
D2= 7.89E-06 3.73E-06 4.02 E-06 5.99E-06 3.40E-06 3.30E-06
SSE= 0.0092506 0.01576627 0.2381145 0.0144352 0.012 0.026
psspdda 61240 63640 66040 61277 63677 66077
D1 = 13.591459 10.2 10.5 15.199701 11.4 11
D2= 3.81 E-06 4.80E-06 3.40E-06 7.75E-06 4.50 E-06 1.80E-06
SSE= 0.0258080 0.024 0.036 0.0149972 0.034 0.36
pvspdda 21240 23640 26040 21277 23677 26077
D1 = 13.288079 11.0090987 10.688615 18.676951 10.709831 9.8895273
D2= 1.17E-05 2.67E-06 2.32 E-06 8.22 E-06 3.13E-06 3.34E-06
SSE= 0.0106521 0.00332407 0.0154420 0.0658148 0.0111052 0.0344934
pvspdda 41240 43640 46040 41277 43677 46077
D1 = 10.671604 10.9032036 10.806467 10.224095 10.968331 10.461454
D2= 5.05E-06 3.43E-06 3.29E-06 5.06E-06 2.19E-06 1.75E-06
SSE= 0.0047195 0.00460433 0.0119969 0.0224955 0.0013996 0.0036612
pvspdda 61240 63640 66040 61277 63677 66077
D1 = 9.3441210 10.7027215 10.964211 10.142274 10.248225 10.486949
D2= 5.27E-06 3.14E-06 2.94E-06 7.95E-06 3.60E-06 2.70E-06
SSE= 0.0410197 0.00834733 0.0028802 0.0131864 0.0389037 0.0222586
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psspah 41240 43640 46040 41277 43677 46077
D1 = 1.94E+02 6.553579 6.423386 6.70E+00 7.574897 6.388522
D2= 2.10E-05 3.15E-06 3.50 E-06 4.20E-06 3.74E-06 3.11 E-06
SSE= 0.067 0.059625 0.004871 0.056 0.03471 0.002657
pvspah 41240 43640 46040 41277 43677 46077
D1 = 18.42723 9.060798 7.467331 6.792011 4.64723
D2= 1.46E-05 4.02E-06 3.82E-06 4.28E-06 3.46E-06
SSE= 0.007494 0.075704 0.04956 0.002008 0.030535
In order to determine the main effects o f membrane type, loading time, dextran 
molecular weight, and number o f layers in the wall membrane on the diffusivity 
coeffiecients D l and D2, an anlysis o f variance was performed on the portion o f the data 
in Table 6.1 that includes psspdda and pvspdda. This excluded psspah and pvspah since 
this data set was only for four layers. Results of the analysis o f variance for D l are 
presented in Table 6.2.
Table 6.2. Analysis of variance for D l (the microcapsule core diffusivity)
S o u rc e DF T ype III S S M ean  S q u a re F V alue P r > F
ty p e 1 36 .7636534 3 6 .7 636534 2 .39  0 .1330
layer 2 3 6 5 .5990966 18 2 .7995483 11.88 0 .0002
tim e 2 11 .8244606 5 .9 1 2 2 3 0 3 0 .38  0 .6844
mw 1 9 .8491392 9 .8 4 9 1 3 9 2 0 .64  0 .4302
From the p values in Table 6.2, it is seen that only layer number has a significant 
effect on D l. Table 6.3 gives pair-wise mean comparisons among the layer means. It is 
seen from the p values in the table that D l is significantly larger for two layers than for 
four layers. However, there is no difference in the D l diffusivity between four and six 
layers.
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Table 6.3. Pair-wise comparisons among the layer means for D l
layer D1 MEAN N um ber
2 16.4327021 E-6 1
4  8 .8 149383E -6  2
6  11 .1483054E -6  3
D ep en d e n t V ariable: D1 
i/j 1 2  3
1 0.0001 0 .0070
2 0.0001 0 .3259
3 0 .0070  0 .3259
cTO
®
E
1.80E-05 
1.60E-05 4 
1.40E-05 
1.20E-05 
1.00E-05 4- 
8.00E-06 
6.00E-06 
4.00E-06 4 
2.00E-06 
0.00E+00
layer number
Figure 6.48. Plot of the mean o f D l against layer number
The plot in Figure 6.48 shows that the mean diffusivity in the core decreases from 
two to four layers, but the difference between four and six is not significant as indicated 
in Table 6.3.
The same analysis o f variance for diffusivity (D2) in the wall membrane is 
presented in Table 6.4.
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Table 6.4. Analysis o f variance for D2 (wall membrane diffusivity)
S o u rc e DF T yp e  III S S M ean S q u a re F V alue P r > F
ty p e 1 8.8804E -12 8 .8804E -12 2.47 0 .1270
layer 2 2.7751 E-11 1.387591 E-11 3 .86 0 .0327
tim e 2 1.53764E -10 7.6882E -11 21 .37 <.0001
mw 1 4 .257344E -12 4 .25 7 3 4 4 E -1 2 1.18 0 .2857
It is seen from the p values in the table that both layer and time have significant 
effects on D2. The pair-wise mean comparisons in Table 6.5 show that D2 decreased 
significantly with an increase in the number o f layers from two to four. However, the 
difference in diffusivity between four and six layers was not significant. These results are 
shown graphically in Figure 6.49. From the pair-wise mean comparisons among the D2 
means for the different loading times (Table 6.6), it is seen that D2 decreased 
significantly from two to four layers. However, the decrease in D2 as the number of 
layers increased from four to six was not significant. These results are shown graphically 
in Figure 6.50.
Table 6.5. Pair-wise comparisons among the layer means for D2
layer D2 MEAN N um ber
2 6 .0 5 1 6667E -6  1
4  4 .0 9 1 6667E -6  2
6 4 .305E -6  3
D ep en d e n t V ariable: D2
i/j 1 2  3
1 0 .0437  0 .0786
2  0 .0437  0.9591
3  0 .0786  0.9591
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Figure 6.49. Plot of the mean of D2 against layer number
Table 6.6. Pair-wise comparisons among the loading time means for D2
tim e D2 MEAN N um ber
12 7 .7 1 5 8 3 3 3 E -6  1
36 3 .6 8 3 3 3 3 3 E -6  2
60  3 .0 4 9 1 667E -6  3
D ep en d e n t V ariable: D2
1 <.0001 <.0001
2 <.0001 0 .6945
3 <.0001 0 .6945
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Figure 6.50. Plot o f the mean o f D2 against loading time
In order to determine the effect of layer type on diffusivity where all four types 
are present, an analysis o f variance on D l and D2 was performed using the data for four 
layers in Table 6.1. It is seen from the p values in Table 6.7 that membrane or layer type, 
loading time, and dextran molecular weight have no effect on diffusivity through the core 
of the microcapsule.
Table 6.7. Analysis o f variance for Dl o f data set two
S o u rc e DF T ype III S S M ean  S q u a re F V alue P r > F
type 3 2 .8 0 1 755E-11 9 .3 3 9 1 8 2 E -12 0 .76 0 .5325
tim e 2  1 .30 1 3 8 1 E-10 6 .5 0 6 9 0 6 E -1 1 5.30 0.0171
mw 1 5 .2 5 8 0 3 9 E -1 1 5 .2 5 8 0 3 9 E -1 1 4 .28 0.0551
From the p values in Table 6.8, it is seen that molecular weight and loading time 
have significant effects on diffusivity in the wall membrane (D2). From the p values in 
Table 6.9, it is seen that the diffusivity in the wall membrane is larger for 12 hours o f 
loading time than for 36 or 60 hours. Diffusivity for 36 hours o f loading time is not
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significantly different from that for 60 hours. These results are shown graphically in 
Figure 6.51.
Table 6.8 Analysis o f variance for D2 o f data set two
S o u rc e  DF T ype III S S  M ean S q u a re  F V alue P r > F
ty p e  3 4 1 0 1 .3 1 8 7 1 6  1367 .106239  0 .92  0 .4525
tim e 2  3 8 4 8 .1 5 0 3 7 3  1924 .075187  1.30 0 .3003
m w 1 2 0 1 4 .1 6 3 4 7 5  2 0 1 4 .1 6 3 4 7 5  1.36 0 .2608
Table 6.9. Pair-wise comparisons among the D2 means o f data set two for loading time
tim e D2 MEAN N um ber 
12 8 .345E -6  1
36  3 .30 4 5 5 8 8 E -6  2
60 3 .36875E -6  3
D ep en d e n t V ariable: D2 
i/j 1 2  3
1 0 .0354  0.0301
2  0 .0354  0 .9993
3 0.0301 0 .9993
9.00E-06 
8.00E-06 -t - 
7.00E-06 
6.00E-06 
2 5.00E-06 
^  4.00E-06 -  
°  3.00E-06 
2.00E-06 
1.00E-06 
0.00E+00
" *- Ky- . ;
12 36 60
loading time
Figure 6.51. Plot o f the mean o f D2 o f data set two against loading time
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It is seen from Table 6.10 that the diffusivity through the wall membrane is 
smaller for 77000 dextran molecular weight than for 4000 molecular weight. The 
decrease in diffusivity with an increase in molecular weight is shown graphically in 
Figure 6.52.
Table 6.10. Mean diffusivity in the membrane wall for 4000 and 77000 dextran 
molecular weights
m w  D2 MEAN P r > |t|
4 0 0 0  6 .5 2 9 1 667E -6  0.0551
7 7000  3 .4830392E -6
7.00E-06
6.00E-06
5.00E-06
JJJ 4.00E-06
N 3.00E-06
2.00E-06
1.00E-06
0.00E+00
4000 77000
molecular weight
Figure 6.52. Plot o f the mean o f D2 o f data set two against weight
6.4 Conclusion
From the analysis o f  variance in Tables 6.2 and 6.3, it is seen that only layer 
thickness had an effect on diffusivity in the core. The diffusivity for four layers was 
almost half o f that for two layers o f polyelectrolytes in the core. In the case o f diffusivity 
in the microcapsule wall, both time and layer thickness had an effect (Tables 6.4 and 6.5).
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In this case, diffusivity was larger for two layers o f wall membrane thickness than for 
four or six layers and it was also larger for 12 hours than for 36 or 60 hours o f loading 
time. There was no significant change in diffusivity beyond four layers or beyond 36 
hours o f loading time. From Tables 6.8 -  6.10, it is interesting to see that for four layers 
o f wall membrane thickness molecular weight had an effect on diffusivity through the 
wall membrane with the high molecular weight diffusing more slowly than the low 
molecular weight. In all analyses, membrane type had no marginal effect on diffusivity 
when considered over all loading times, membrane thickness, and molecular weight.
6.5 Future W ork
In the future work, it would be o f interest to modify the diffusion model to include 
only the release stage and apply it to data where dextran is initially encapsulated in the 
core. In this case, one may gain a clearer insight about the nature o f diffusivity inside the 
core and wall membrane of the microcapsules.
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